References of "Bastings, E"
     in
Bookmark and Share    
See detailSodium Valproate in Severe Migraine and Tension-Type Headache: An Open Study of Long-Term Efficacy and Correlation with Blood Levels
Lenaerts, M.; Bastings, E.; Sianard, J. et al

in Acta Neurologica Belgica (1996), 96(2), 126-9

We performed an open prospective study of the prophylactic efficacy of sodium valproate in 56 patients among which 35 migraineurs, 7 chronic tension-type headache patients and 14 patients with combined ... [more ▼]

We performed an open prospective study of the prophylactic efficacy of sodium valproate in 56 patients among which 35 migraineurs, 7 chronic tension-type headache patients and 14 patients with combined headaches. We compared the mean number of headache days per month during a one-month-baseline period without prophylactic treatment and during the last month of a 6-month-treatment course. Among secondary parameters, we assessed headache intensity, adverse experiences and we measured valproate blood levels after one and after six months of treatment. Sixty percent of migraineurs had a 75% or more improvement in the number of headache days under sodium valproate, most of the remaining attacks being less severe. There was no significant improvement in chronic tension-type headache patients and only a mild effect in patients with combined headaches, almost exclusively on the migraine component. Thirty percent of patients reported adverse effects of which none was serious: there were 3 drop-outs. We found a moderate, but statistically significant, correlation between efficacy and blood levels of sodium valproate. [less ▲]

Detailed reference viewed: 20 (1 ULg)
See detailHigh-Dose Riboflavin as a Prophylactic Treatment of Migraine: Results of an Open Pilot Study
Schoenen, Jean ULg; Lenaerts, M.; Bastings, E.

in Cephalalgia : An International Journal of Headache (1994), 14(5), 328-9

If the brain of migraineurs is characterized between attacks by a reduction of mitochondrial phosphorylation potential, riboflavin, which has the potential of increasing mitochondrial energy efficiency ... [more ▼]

If the brain of migraineurs is characterized between attacks by a reduction of mitochondrial phosphorylation potential, riboflavin, which has the potential of increasing mitochondrial energy efficiency, might have prophylactic effects in migraine. In this preliminary open pilot study, 49 patients suffering from migraine (45 without aura, 4 with aura) were treated with 400 mg of riboflavin as a single oral dose for at least 3 months. Twenty-three patients received in addition 75 mg of aspirin. Mean global improvement after therapy was 68.2% and there was no difference between the two groups of patients. With the exception of one patient in the riboflavin plus aspirin group who withdrew because of gastric intolerance, no drug-related side effects were reported. High-dose riboflavin could thus be an effective, low-cost prophylactic treatment of migraine devoid of short-term side effects. A placebo-controlled trial of its efficacy seems worthwhile. [less ▲]

Detailed reference viewed: 24 (0 ULg)
Full Text
See detailImmunocytochemical evidence for production of luteinizing hormone and follicle-stimulating hormone in separate cells in the bovine.
Bastings, E.; Beckers, Albert ULg; Reznik, Michel ULg et al

in Biology of Reproduction (1991), 45(5), 788-96

In all mammalian females, follicular growth and maturation are essentially dependent on the pituitary gonadotropins, FSH and LH. These glycoprotein hormones have many similarities, but their action, based ... [more ▼]

In all mammalian females, follicular growth and maturation are essentially dependent on the pituitary gonadotropins, FSH and LH. These glycoprotein hormones have many similarities, but their action, based on high affinity binding to specific membrane receptors, are quite different. The purpose of this study was to perform a sensitive localization of FSH and LH in secretory granules of gonadotrophs using highly specific antisera. This morphological study included light microscopy (PAP) and electron microscopy (immunogold single and double labeling) procedures. Histologically, approximatively 11.5% of cells were positive for LH, whereas only 5.4% of cells were positive for FSH. With the electron microscope, single labeling allowed identification of morphologically distinct LH-containing cells and FSH-containing cells. Double immunostaining confirmed that no cells contained both hormones. The finding that FSH and LH are produced in separate pituitary cells is in agreement with recent studies that have suggested a specific role and regulatory process for gonadotropins in the bovine species. [less ▲]

Detailed reference viewed: 13 (3 ULg)
See detailLocalization of gonadotropins in pituitaries of various animals especies and in humans
Bastings, E.; Beckers, Albert ULg; Reznik, M. et al

in de la Cruz, L. F.; Garcia Luna, M. T. (Eds.) Recent advances in growth and reproduction (1990)

Detailed reference viewed: 2 (0 ULg)
See detailImmunocytochemical evidence that LH and FSH are produced by distinct cells in bovine pituitary.
Bastings, E.; Beckers, Albert ULg; Reznik, M. et al

in Theriogenology January (1990)

Detailed reference viewed: 1 (1 ULg)
See detailGonadotropin secretion in the bovine : localization of LH and FSH in pituitaries by electron microscopy.
Bastings, E.; Beckers, Albert ULg; Reznik, M. et al

in Journal of Endocrinological Investigation (1990)

Detailed reference viewed: 3 (0 ULg)
See detailThe treatment of acromegaly with SMS 201-995
Beckers, Albert ULg; Stevenaert, Achille ULg; Kovacs, K. et al

in Landolt, A. M.; Heitz, P. U.; Zapf, J. (Eds.) et al Advances in Pituitary Adenoma Research (Advances in the Biosciences) (1988)

Detailed reference viewed: 3 (0 ULg)
See detailSMS 201-995 can exert a direct analgesic effect
Beckers, Albert ULg; Stevenaert, Achille ULg; Bastings, E. et al

in Lamberts, S. W. J. (Ed.) Sandostatin in the treatment of acromegaly (1988)

Detailed reference viewed: 1 (0 ULg)
See detailRelapsing acromegaly resistant to both Parlodel and Sandostatin treatment
Beckers, Albert ULg; Stevenaert, Achille ULg; Bastings, E. et al

in Lamberts, S. W. J. (Ed.) Sandostatin in the treatment of acromegaly (1988)

Detailed reference viewed: 4 (0 ULg)
See detailExperience with Sandostatin in various groups of agromegalic patients
Stevenaert, Achille ULg; Beckers, Albert ULg; Kovacs, K. et al

in Lamberts, S. W. J. (Ed.) Sandostatin in the treatment of acromegaly (1988)

Detailed reference viewed: 4 (0 ULg)
See detailLe traitement de l'acromégalie par SMS 201-995 : résultats obtenus chez 38 patients.
Beckers, Albert ULg; Stevenaert, A.; Bastings, E. et al

in Annales d'Endocrinologie (1988)

Detailed reference viewed: 11 (1 ULg)